These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17854050)

  • 21. The role of polymer concentration on the molecular mobility and physical stability of nifedipine solid dispersions.
    Kothari K; Ragoonanan V; Suryanarayanan R
    Mol Pharm; 2015 May; 12(5):1477-84. PubMed ID: 25894099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The glass transition and dielectric secondary relaxation of fructose-water mixtures.
    Shinyashiki N; Shinohara M; Iwata Y; Goto T; Oyama M; Suzuki S; Yamamoto W; Yagihara S; Inoue T; Oyaizu S; Yamamoto S; Ngai KL; Capaccioli S
    J Phys Chem B; 2008 Dec; 112(48):15470-7. PubMed ID: 18991437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between molecular mobility and crystal growth of amorphous phenobarbital and phenobarbital with polyvinylpyrrolidone and L-proline.
    Korhonen O; Bhugra C; Pikal MJ
    J Pharm Sci; 2008 Sep; 97(9):3830-41. PubMed ID: 18200526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerated Physical Stability Testing of Amorphous Dispersions.
    Mehta M; Suryanarayanan R
    Mol Pharm; 2016 Aug; 13(8):2661-6. PubMed ID: 27299377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of mechanical stress in crystallization and relaxation behavior of amorphous indomethacin.
    Bhugra C; Shmeis R; Pikal MJ
    J Pharm Sci; 2008 Oct; 97(10):4446-58. PubMed ID: 18228583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between Molecular Mobility and Physical Stability in Pharmaceutical Glasses.
    Mehta M; Ragoonanan V; McKenna GB; Suryanarayanan R
    Mol Pharm; 2016 Apr; 13(4):1267-77. PubMed ID: 26895136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular dynamics simulation of amorphous indomethacin.
    Xiang TX; Anderson BD
    Mol Pharm; 2013 Jan; 10(1):102-14. PubMed ID: 23116319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility.
    Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
    J Pharm Sci; 2002 Aug; 91(8):1863-72. PubMed ID: 12115813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical Estimation of Amorphous Solubility Enhancement Using Thermoanalytical Data: Determination of the Amorphous/Crystalline Solubility Ratio for Pure Indomethacin and Felodipine.
    Skrdla PJ; Floyd PD; Dell'orco PC
    J Pharm Sci; 2016 Sep; 105(9):2625-2630. PubMed ID: 27372548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting Crystallization of Amorphous Drugs with Terahertz Spectroscopy.
    Sibik J; Löbmann K; Rades T; Zeitler JA
    Mol Pharm; 2015 Aug; 12(8):3062-8. PubMed ID: 26090554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of water vapor absorption on the physical and chemical stability of amorphous sodium indomethacin.
    Tong P; Zografi G
    AAPS PharmSciTech; 2004 Mar; 5(2):e26. PubMed ID: 15760084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of different calorimetric methods to determine the glass transition temperature and molecular mobility below T(g) for amorphous drugs.
    Weuts I; Kempen D; Six K; Peeters J; Verreck G; Brewster M; Van den Mooter G
    Int J Pharm; 2003 Jun; 259(1-2):17-25. PubMed ID: 12787632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mobility in glass forming fananserine: a dielectric, NMR, and TMDSC investigation.
    Carpentier L; Decressain R; De Gusseme A; Neves C; Descamps M
    Pharm Res; 2006 Apr; 23(4):798-805. PubMed ID: 16575499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calorimetric study and modeling of molecular mobility in amorphous organic pharmaceutical compounds using a modified Adam-Gibbs approach.
    Mao C; Chamarthy SP; Pinal R
    J Phys Chem B; 2007 Nov; 111(46):13243-52. PubMed ID: 17967007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface crystallization of indomethacin below Tg.
    Wu T; Yu L
    Pharm Res; 2006 Oct; 23(10):2350-5. PubMed ID: 16927184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystallization rate of amorphous nifedipine analogues unrelated to the glass transition temperature.
    Miyazaki T; Yoshioka S; Aso Y; Kawanishi T
    Int J Pharm; 2007 May; 336(1):191-5. PubMed ID: 17184940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of molecular mobility on the physical stability of amorphous pharmaceuticals in the supercooled and glassy States.
    Kothari K; Ragoonanan V; Suryanarayanan R
    Mol Pharm; 2014 Sep; 11(9):3048-55. PubMed ID: 25105216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of α-relaxation on crystallization of amorphous celecoxib above T(g) probed by dielectric spectroscopy.
    Dantuluri AK; Amin A; Puri V; Bansal AK
    Mol Pharm; 2011 Jun; 8(3):814-22. PubMed ID: 21534589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Amorphous Drug Stability Predictions Using Easily Calculated, Predicted, and Measured Parameters.
    Nurzyńska K; Booth J; Roberts CJ; McCabe J; Dryden I; Fischer PM
    Mol Pharm; 2015 Sep; 12(9):3389-98. PubMed ID: 26236939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin.
    Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
    Mol Pharm; 2008; 5(6):927-36. PubMed ID: 19434849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.